MY127989A - Treatment of neuropathy - Google Patents
Treatment of neuropathyInfo
- Publication number
- MY127989A MY127989A MYPI20004933A MY127989A MY 127989 A MY127989 A MY 127989A MY PI20004933 A MYPI20004933 A MY PI20004933A MY 127989 A MY127989 A MY 127989A
- Authority
- MY
- Malaysia
- Prior art keywords
- treatment
- neuropathy
- inhibitors
- relates
- phosphodiesterase type
- Prior art date
Links
- 201000001119 neuropathy Diseases 0.000 title abstract 2
- 230000007823 neuropathy Effects 0.000 title abstract 2
- 208000033808 peripheral neuropathy Diseases 0.000 title abstract 2
- ZOOGRGPOEVQQDX-UUOKFMHZSA-N 3',5'-cyclic GMP Chemical compound C([C@H]1O2)OP(O)(=O)O[C@H]1[C@@H](O)[C@@H]2N1C(N=C(NC2=O)N)=C2N=C1 ZOOGRGPOEVQQDX-UUOKFMHZSA-N 0.000 abstract 2
- BNRNXUUZRGQAQC-UHFFFAOYSA-N sildenafil Chemical compound CCCC1=NN(C)C(C(N2)=O)=C1N=C2C(C(=CC=1)OCC)=CC=1S(=O)(=O)N1CCN(C)CC1 BNRNXUUZRGQAQC-UHFFFAOYSA-N 0.000 abstract 2
- 208000032131 Diabetic Neuropathies Diseases 0.000 abstract 1
- 101100189582 Dictyostelium discoideum pdeD gene Proteins 0.000 abstract 1
- 101150098694 PDE5A gene Proteins 0.000 abstract 1
- 102000004861 Phosphoric Diester Hydrolases Human genes 0.000 abstract 1
- 108090001050 Phosphoric Diester Hydrolases Proteins 0.000 abstract 1
- 102100029175 cGMP-specific 3',5'-cyclic phosphodiesterase Human genes 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- ZOOGRGPOEVQQDX-UHFFFAOYSA-N cyclic GMP Natural products O1C2COP(O)(=O)OC2C(O)C1N1C=NC2=C1NC(N)=NC2=O ZOOGRGPOEVQQDX-UHFFFAOYSA-N 0.000 abstract 1
- 239000003112 inhibitor Substances 0.000 abstract 1
- 229960003310 sildenafil Drugs 0.000 abstract 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
THIS INVENTION RELATES TO THE USE OF CYCLIC GUANOSINE 3', 5'- MONOPHOSPHATE PHOSPHODIESTERASE TYPE FIVE (cGMP PDE5) INHIBITORS, INCLUDING IN PARTICULAR THE COMPOUND SILDENAFIL, FOR THE TREATMENT OF NEUROPATHY, INCLUDING IN PARTICULAR THE TREATMENT OF DIABETIC NEUROPATHY.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9924958.3A GB9924958D0 (en) | 1999-10-21 | 1999-10-21 | Treatment of neuropathy |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MY127989A true MY127989A (en) | 2007-01-31 |
Family
ID=10863154
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MYPI20004933 MY127989A (en) | 1999-10-21 | 2000-10-19 | Treatment of neuropathy |
| MYPI20024290 MY138266A (en) | 1999-10-21 | 2000-10-19 | Treatment of neuropathy |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MYPI20024290 MY138266A (en) | 1999-10-21 | 2000-10-19 | Treatment of neuropathy |
Country Status (3)
| Country | Link |
|---|---|
| GB (1) | GB9924958D0 (en) |
| MY (2) | MY127989A (en) |
| NZ (1) | NZ507690A (en) |
-
1999
- 1999-10-21 GB GBGB9924958.3A patent/GB9924958D0/en not_active Ceased
-
2000
- 2000-10-19 MY MYPI20004933 patent/MY127989A/en unknown
- 2000-10-19 MY MYPI20024290 patent/MY138266A/en unknown
- 2000-10-20 NZ NZ50769000A patent/NZ507690A/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| MY138266A (en) | 2009-05-29 |
| NZ507690A (en) | 2002-10-25 |
| GB9924958D0 (en) | 1999-12-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP1129706A3 (en) | Use of cGMP PDE5 inhibitors for the treatment of neuropathy | |
| MY135909A (en) | Treatment of pulmonary hypertension | |
| NO995211D0 (en) | Pyrazole pyrimidinones inhibiting cyclic guanosine 3 ', 5'-monophosphate phosphodiesterase type 5 (cGMP PDE5), for the treatment of sexual dysfunction | |
| WO2002102314A3 (en) | Purine inhibitors of phosphodiesterase (pde) 7 | |
| DE60202134D1 (en) | Zyklische guanosine 3',5'-monophosphate phosphodiesterase inhibitoren | |
| WO2002000657A3 (en) | Condensed pyrazindione derivatives | |
| SE0001518D0 (en) | Pharmaceutical composition | |
| ZA200205694B (en) | Treatment of diabetic ulcers. | |
| MY131573A (en) | Use of pde5 inhibitors for the treatment of premature ejaculation | |
| MY127989A (en) | Treatment of neuropathy | |
| AU2002234835A1 (en) | Cyclic guanosine 3',5'-monophosphate phosphodiesterase inhibitors | |
| IL157647A0 (en) | INTERMEDIATES FOR PYRAZOLOPYRIMIDINONES WHICH INHIBIT TYPE 5 CYCLIC GUANOSINE 3',5'-MONOPHOSPHATE PHOSPHODIESTERASE (cGMP PDE5) FOR THE TREATMENT OF SEXUAL DYSFUNCTION |